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Abstract: In this study we have showed that
zinc ion has an inhibitory activity on
imipenem and meropenem suspectibility of
Pseudomonas aeruginosa. When zinc ion
concentration of Mueller-Hinthon agar
(MHA) media was gradually increased the
zone diameters of imipenem and meropenem
gradually decreased. So we concluded that
zinc concentration in the media might effect
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Introduction
Imipenem and meropenem are broad-spectrum
carbapenem antibiotics with activity against Pseudomonas
aeruginosa (1-3). Beta-lactam rings of these antibiotics
are resistant to hydrolysis by most beta-lactamases (4-5)
and the activity of meropenem against most clinical
isolates was comparable to imipenem (6). Thus these
agents can be used in the treatment of infections caused
by Pseudomonas aeruginosa isolates which are resistant
to some groups of antibiotics (2-7). But there is some
evidence that suggests false resistance of Pseudomonas
aeruginosa to imipenem (8). Although this is partly
attributed to the loss of drug activtiy during storage and
it is also showed that the zinc concentration in the media
would affect the imipenem susceptibility of Pseudomonas
aeruginosa (9). Like this we also showed that the
pencentage of pseudomonas aeruginosa isolates resistant
to imipenem significantly increased in zinc-supplemented
media (10).
In this study we wanted to observe the effects of zinc
on imipenem and especially on meropenem against
Pseudomonas aeruginosa by using the Kirby-Bauer
method at various zinc concentrations.
Materials and Methods
In this study a total of 16 Pseudomonas aeruginosa
isolates were studied. These isolates were obtained from

imipenem and meropenem susceptibility of
Pseudomonas aeruginosa and might indicate
false resistance to imipenem and
meropenem. Therefore the use of these
antipseudomonal antibiotics in Pseudomonas
infections may be restricted.
Key Words: P.aeruginosa, Zinc, Imipenem,
Meropenem

the Microbiology Laboratory of the Medical Faculty of
Dicle University. Fresh isolates were grown on MHA
(Oxoid) for 24 hours at 37˚C before use in each phase of
the investigation. Control strain tested throughout the
study was Pseudomonas aeruginosa ATCC 27853.
Previously we had quantified the zinc concentration in the
Oxoid MHA was 0.45 µg/ml (10). By adding zinc acetate
in this media we increased zinc concentration of the
media to 3 µg/ml. This concentration is very similar to
2.61 µg/ml which was quantified in BBL MHA (Lot no:
H2DWFX) (9).
Sixteen isolates of Pseudomonas aeruginosa were
adjusted to an optical density of 0.5 Mc Farland standart
(108 cfu/ml) with sterile saline and then further diluted to
achive a final bacterial concentration of 107 cfu/ml. The
same bacterial isolates were grown on Oxoid MHA and
zinc-supplemented Oxoid MHA. The antibiotic
susceptibilities of Pseudomonas aeruginosa to imipenem
(Lot no: Ch-B.40866, Oxoid) and meropenem (Lot
no:45611, Oxoid) determined by Kirby-Bauer methods
(11) on Oxoid MHA and zinc-supplemented Oxoid MHA
after incubation of at 37˚C for 24 hours. In all of these
media, we obtained the zone diameters of imipenem and
meropenem against Pseudomonas aeruginosa.
Results are expressed as mean ± SEM for sixteen
experiments. If appropriate one-way paired or unpaired
student’s t test were used for statistical comparison.
P<0.05 was considered to be significant.
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Results

When zinc-supplemented Oxoid MHA was used the
zone diameters of imipenem and meropenem against
Pseudomonas aeruginosa isolates decreased (P<0.05).
Observetaions for the control strain (Pseudomonas
aeruginosa ATCC 27853) was similar to observation for
the test strains (data not shown).

The results of the susceptibility testing of
Pseudomonas aeruginosa isolates to imipenem and
meropenem on Oxoid MHA and zinc-supplemented Oxoid
MHA are shown in the table. All of these isolates used in
this study were susceptible to imipenem and meropenem,
however these isolates were more susceptible to
meropenem than imipenem (P<0.005). The zone
diameters of 16 isolates of Pseudomonas aeruginosa
were 22±1.6 mm and 26.5±1.8 mm againts imipenem
and meropenem respectively.

Table 1.

The susceptibilities of Pseudomonas aeruginosa
isolates to imipenem and meropenem related with two
different zinc concentrations are shown in the figure.
Discussion
The interest on the effect of zinc cation content in the
media on imipenem susceptibility has been recently
increased. And addition of zinc to Difco MHA (Lot
no:780100) resulted in increases in MICs of imipenem
for Pseudomonas aeruginosa but not in the MICs of some
antibiotics (9). Similarly we observed that when zinc
supplemented media was used the percentage of
Pseudomonas aeruginosa isolates resistant to imipenem
was significantly increased (10).

The susceptibilityes of Pseudomonas aeruginosa isolates to
imipenem and meropenem in two different amounts of zinc
containing media (n:16). Each value represents mean±SEM
of sixteen zone diameters.

Zinc Concentration

0.45

in MHA (µg/ml) (a)

(b)

*Imipenem zone

3

22±1.6

19.4±1.8

26.5±1.8

23.4±1

Imipenem and meropenem are carbapenem antibiotics
and knowledge of the action of these beta-Lactam
antibiotics is incomplete (12). These antibiotics pass
through the outer membrane of gram-negative bacteriå
via the water-filled porin channels (13) to reach their
targest, penicillin binding proteins (14). Deletion or
diminished production of these outer membrane proteins
(porins) decreases outher membrane permeability of
some gram-negative bacteria for diffusion of these
antibiotics and decreases susceptibility to imipenem and
meropenem (2, 15, 16). Although it is not clear at the

diatemers (mm)
**Meropenem zone
diameters (mm)

* ab: P<0.05
** ab: P<0.05

Figure 1.
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µg/ml

The susceptibility of P.aeruginosa
isolates to imipenem and
meropenem. Each point represents
mean of sixteen zone diameters
and SEM.
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present time whether the porins are the only route of
penetration of betalactam antibiotics, in particular for
carbapenems it is probable that zinc would have to alter
porins or decrease expression of multible porin proteins.
If this is so we can explain why imipenem and meropenem
zone diameters were inversely related to zinc
concentration in the media. But some authors claim that
the loss of porins alone should not cause resistance to a
carbapenem (17).
The production of beta-lactamases had little influence
on susceptibility to either meropenem or imipenem
except the production of metalloenzymes capable of the
hydrolyzing the carbanepenems, strains expessing high
levels of these enzymes were resistant to both
meropenem and imipenem (18). We know plasmidencoded zinc-dependent beta-lactamase of Pseudomonas
aeruginosa hydrolysis imipenem (19). But really we don’t
know whether zinc supplemented media affect the
production of this type any enzyme or not.
Many antibiotics including beta-lactams can use porin

pathway to enter in to the periplasm (20). Principal lethal
target of carbapenem antibiotics in the cell are penicillinbinding proteins (21). Meropenem binds to penicillinbinding protein 3 and imipenem binds to penicillinbinding protein 2 (22). Zinc is known to affect penicilin
binding protein-beta-lactam-interaction, but this effect
has not been demonstrated in Pseudomonas aeruginosa.
So the role of zinc ion on the carbapenems and penicillinbinding proteins of Pseudomonas aeruginosa isolates are
not established.
Finally the real reasons for these observations are
unknown and it is difficult to explain these results by any
certainity. But we certainly showed that the zinc content
in the Oxoid MHA does affect the activity of imipenem
and of meropenem against Pseudomonas aeruginosa. The
zone diameters of imipenem and meropenem against
Pseudomonas aeruginosa isolates, obtained on Oxoid
MHA with a high zinc content, are smaller: These
observations may indicate false resistance to imipenem
and meropenem and restrict the use of these
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